Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

Autor: Staffan Persson, Uroš Rot, Giovanni B. Frisoni, María Salud García-Ayllón, Hanne Struyfs, Inês Baldeiras, André Janeiro, Julia T. Tanassi, Davide Chiasserini, Andreja Emeršič, Norbert Zilka, Maria João Leitão, Eugeen Vanmechelen, Tormod Fladby, Luisella Bocchio Chiavetto, Henrik Zetterberg, Niels Kruse, Justyna M.C. Bahl, H. Bea Kuiperij, Javier Sáez-Valero, Madalena Martins, Branislav Kovacech, Erden Eren, Hanne M. Møllergård, Daniel Alcolea, Annika Öhrfelt, Alberto Lleó, Catarina R. Oliveira, Mafalda Matos, Marcel M. Verbeek, Lucilla Parnetti, Magda Tsolaki, Kaj Blennow, Brit Mollenhauer, Niels H. H. Heegaard, Elisabetta Capello, Flavio Nobili, Sebastiaan Engelborghs, Olymbia Gkatzima, Sermin Genc, Peggy Taylor

Publikováno v: Neurobiology of aging
Neurobiology of Aging, 36, 2587-96
NEUROBIOL AGING
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Neurobiology of Aging, 36, 9, pp. 2587-96
NEUROBIOLOGY OF AGING
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Kruse, N, Persson, S, Alcolea, D, Bahl, J M C, Baldeiras, I, Capello, E, Chiasserini, D, Chiavetto, L B, Emersic, A, Engelborghs, S, Eren, E, Fladby, T, Frisoni, G, Garcia-Ayllon, M S, Genc, S, Gkatzima, O, Heegaard, N H H, Janeiro, A M, Kovacech, B, Kuiperij, H B, Leitao, M J, Lleo, A, Martins, M, Matos, M, Mollergard, H M, Nobili, F, Ohrfelt, A, Parnetti, L, de Oliveira, C R, Rot, U, Saez-Valero, J, Struyfs, H, Tanassi, J T, Taylor, P, Tsolaki, M, Vanmechelen, E, Verbeek, M M, Zilka, N, Blennow, K, Zetterberg, H & Mollenhauer, B 2015, ' Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study ', Neurobiology of Aging, vol. 36, no. 9, pp. 2587-2596 . https://doi.org/10.1016/j.neurobiolaging.2015.05.003
r-FISABIO. Repositorio Institucional de Producción Científica
Neurobiology of Aging, Vol. 36, No 9 (2015) pp. 2587-96
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau

© 2015 Elsevier Inc. All rights reserved.
Decreased levels of alpha-synuclein (aSyn) in cerebrospinal fluid (CSF) in Parkinson's disease and related synucleinopathies have been reported, however, not consistently in all cross-sectional studies.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b3cd9f0240aade316cff1d05d000041
https://hdl.handle.net/10067/1263120151162165141

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

Autor: Armand Perret-Liaudet, Marcel M. Verbeek, Brit Mollenhauer, Lucilla Parnetti, Andrea Urbani, Charlotte E. Teunissen, Esen Saka, Antonio Bertolotto, Eugeen Vanmechelen, Sylvain Lehmann, Pieter Jelle Visser, Harald Hampel, Anja Hviid Simonsen, Nathalie Le Bastard, José Luis Molinuevo, Marta Del Campo, Niels Kruse, Javier Sáez-Valero, Sebastiaan Engelborghs, Elisabeth Kapaki

Publikováno v: Biomarkers in Medicine, 6, 419-30
Biomarkers in Medicine, 6, 4, pp. 419-30
del Campo, M, Mollenhauer, B, Bertolotto, A, Engelborghs, S, Hampel, H, Simonsen, A H, Kapaki, E, Kruse, N, Le Bastard, N, Lehmann, S, Molinuevo, J L, Parnetti, L, Perret-Liaudet, A, Saez-Valero, J, Saka, E, Urbani, A, Vanmechelen, E, Verbeek, M, Visser, P J & Teunissen, C E 2012, ' Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update ', Biomarkers in medicine, vol. 6, no. 4, pp. 419-430 . https://doi.org/10.2217/BMM.12.46
Biomarkers in medicine, 6(4), 419-430. Future Medicine Ltd.
Digital.CSIC. Repositorio Institucional del CSIC
instname
Biomarkers in medicine
Biomarkers in Medicine, 6(4), 419-430. Future Medicine Ltd.

Sáez-Valero, Javier, [et al.]
Early diagnosis of neurodegenerative disorders such as Alzheimers (AD) or Parkinsons disease (PD) is needed to slow down or halt the disease at the earliest stage. Cerebrospinal fluid (CSF) biomarkers can be a good

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6707c33ca807c6e2e80d96646ebab60
http://hdl.handle.net/2066/109299